Added to YB: 2026-06-01
Pitch date: 2026-05-28
VASO [neutral]
Vaso Corporation
Author Info
The Clinical Edge researches and shares thesis-driven ideas on potential healthcare multibaggers. Sign up for the newsletter.
Company Info
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally.
Market Cap
$37.3M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.90
P/E
21.23
EV/Sales
0.05
Sector
Health Care Equipment and Supplies
Category
value
Vaso Corporation (OTCQX: VASO)
VASO (earnings): Q1 rev $19.4M (-0.5% YoY, but +4.8% ex-divestiture); deferred rev record $39.5M (+11.6%); net loss narrowed to $887K. GE deal secured to 2030, segment +6.1%. Stock $0.23 vs $0.22 cash/share—mispricing closed. Watch Q2: $12.6M cash burn (timing?) & SG&A +2.6% despite divestiture.
Read full article (4 min)